When the ship comes in – COVID-19-Ausbrüche an Bord von Frachtschiffen im Hamburger Hafen

ZUSAMMENFASSUNG

Seit Dezember 2019 hält das SARS-CoV-2-Virus die Welt in Atem. Die maritime Welt wird von der Pandemie vielfältig getroffen. Reiserestriktionen schränken den Nachschub von z. B. Ersatzteilen ein und behindern den Crewwechsel massiv. Reguläre und irreguläre Kontakte zur Bevölkerung der jeweiligen Häfen ermöglichen einen Eintrag des Virus in das Schiff. Beengte Lebensverhältnisse an Bord tragen zu einer Ausbreitung des Virus bei. Wir berichten über 2 Ausbruchsgeschehen an Bord von Frachtschiffen, die in ihrer Komplexität die infektionsepidemiologischen Herausforderungen schlaglichtartig beleuchten.

ABSTRACT

Since December 2019 COVID-19 rules our daily life. Due to its international nature the maritime sector is striven hardly by the pandemic. Travel-restrictions limit the supply with spare parts and crew change. Regular and irregular contact to the land based population facilitates the import of the virus on the ship. Living in confined spaces with limited air exchange promotes the spread of the disease. We report on the course of 2 outbreaks of COVID-19 on board cargo-ships in the port of Hamburg. The complexity of their course illuminates the epidemiological challenges port health authorities are facing in the current situation.

Key words

COVID-19 - port health authority - SARS-CoV-2 - infectious disease outbreaks - maritime - cargo ship - communicable diseases

Publication History

Publication Date:
11 February 2021 (online)

• Literatur

• 1 Furukawa NW, Brooks JT, Sobel J.. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic. Emerg Infect Dis 2020; Jul 26: e201595
• 2 Kim SE, Jeong HS, Yu Y. et al Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. Int J Infect Dis 2020; 95: 441-443
• 3 Kimball A, Hatfield KM, Arons M. et al Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 377-381
• 4 Li G, Li W, He X. et al Asymptomatic and Presymptomatic Infectors: Hidden Sources of Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 2020; 71: 2018
• 5 Moriarty LF, Plucinski MM, Marston BJ. et al Public Health Responses to COVID-19 Outbreaks on Cruise Ships – Worldwide, February-March 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 347-352
• 6 Zimmerman RA. When the Ship Comes in. In: The Times They Are A-Changin’. Columbia Records: 1963
• 7 International Maritime Organization. Coronavirus (COVID-19) – Recommended framework of protocols for ensuring safe ship crew changes and travel during the coronavirus (COVID-19) pandemic. Circular Letter No. 4204/Add14/Rev. 1, 5 October 2020
• 8 Hansen CD, Andersen JH. Going ill to work – what personal circumstances, attitudes and work-related factors are associated with sickness presenteeism?. Soc Sci Med 2008; 67: 956-964
• 9 Boccaccio G. Das Dekameron. Erstdruck: Venedig 1470 München: Winkler; 1964
• 10 Robert Koch-Institut. Kernkapazitäten von gemäß Art. 20 Absatz 1 IGV benannten Seehäfen für den Bereich der übertragbaren Krankheiten zur Durchführung der internationalen Gesundheitsvorschriften (2005; IGV) in Deutschland. Bundesgesundheitsbl. 2018; 61: 1196-1204
• 11 Robert Koch-Institut. Kernkapazitäten von gemäß Art. 20 Absatz 1 IGV benannten Flughäfen für den Bereich der übertragbaren Krankheiten zur Durchführung der internationalen Gesundheitsvorschriften (2005; IGV) in Deutschland. Bundesgesundheitsbl. 2018; 61: 1187-1195
• 12 Robert Koch-Institut. Joint External Evaluation (JEE). 27.01.2020. Im Internet. www.rki.de/DE/Content/Infekt/IGV/JEE.html
• 13 World Health Organization. Operational considerations for managing COVID-19 cases or outbreaks on board ships: interim guidance, 25 March 2020. WHO Reference Number: WHO/2019-nCoV/Ships/2020.2
• 14 EU Healthy Gateways. Advice for ship operators for preparedness and response to the outbreak of COVID-19. Version 3. 20 February 2020
• 15 Umweltbundesamt. Das Risiko einer Übertragung von SARS-CoV-2 in Innenräumen lässt sich durch geeignete Lüftungsmaßnahmen reduzieren. Stellungnahme der Kommission Innenraumlufthygiene am Umweltbundesamt. Stand: 12. August 2020
• 16 Dahl E. Coronavirus (Covid-19) outbreak on the cruise ship Diamond Princess. Int Marit Health 2020; 71: 5-8
• 17 Nakazawa E, Ino H, Akabayashi A.. Chronology of COVID-19 Cases on the Diamond Princess Cruise Ship and Ethical Considerations: A Report From Japan. Disaster Med Public Health Prep 2020: 1-8
• 18 Rocklöv J, Sjödin H, Wilder-Smith A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med 2020; 27: taaa030
• 19 Kakimoto K, Kamiya H, Yamagishi T. et al Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 312-313
• 20 Qiu J.. Covert coronavirus infections could be seeding new outbreaks. Nature 2020 Mar 20 [Online ahead of print]
• 21 Kasper MR, Geibe JR, Sears CL. et al An Outbreak of Covid-19 on an Aircraft Carrier. N Engl J Med 2020 Nov 11 [Online ahead of print]
• 22 Robert Koch-Institut. Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19. Im Internet www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html
• 23 Mizumoto K, Kagaya K, Zarebski A. et al Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020; 25: 2000180
• 24 World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020 WHO reference number: WHO/COVID-19/laboratory/2020.4
• 25 Robert Koch-Institut. Hinweise zur Testung von Patienten auf Infektion mit dem neuartigen Coronavirus SARS-CoV-2. Im Internet www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Vorl_Testung_nCoV.html
• 26 Cerutti F, Burdino E, Milia MG. et al Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J Clin Virol 2020; 132: 104654
• 27 Diao B, Wen K, Zhang J. et al Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect 2020: Oct 5 [Online ahead of print]
• 28 Mak GC, Cheng PK, Lau SS. et al Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol 2020; 129: 104500
• 29 Krüger LJ, Gaeddert M, Köppel L. et al Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2; medRxiv 2020. Posted October 04, 2020
• 30 Corman VM, Haage VC, Bleicker T. et al Comparison of seven commercial SARS-CoV-2 rapid Point-of-Care Antigen tests. medRxiv. 2020 Posted November 13, 2020
• 31 Dinnes J, Deeks JJ, Adriano A. et al Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2020: CD013705
• 32 World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020. WHO Reference Number: WHO/2019-nCoV/Antigen_Detection/2020.1
• 33 Weiss A, Jellingsø M, Sommer MOA.. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis. EBioMedicine. 2020: 102916
• 34 Arons MM, Hatfield KM, Reddy SC. et al Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med 2020; 382: 2081-2090
• 35 Bullard J, Dust K, Funk D. et al Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis 2020 May 22 [Online ahead of print]
• 36 Caini S, Bellerba F, Corso F. et al Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications. Euro Surveill 2020; 25: 2000980
• 37 Michael-Kordatou I, Karaolia P, Fatta-Kassinos D. Sewage analysis as a tool for the COVID-19 pandemic response and management: the urgent need for optimised protocols for SARS-CoV-2 detection and quantification. J Environ Chem Eng 2020; 8: 104306
• 38 Orive G, Lertxundi U, Barcelo D. Early SARS-CoV-2 outbreak detection by sewage-based epidemiology. Sci Total Environ 2020; 732: 139298
• 39 Wang XW, Li J, Guo T. et al Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital of the Chinese People’s Liberation Army. Water Sci Technol 2005; 52: 213-221
• 40 Wang XW, Li JS, Guo TK. et al [Detection of RNA of SARS coronavirus in hospital sewage]. Zhonghua Yu Fang Yi Xue Za Zhi 2004; 38: 257-260
• 41 Wang XW, Li JS, Guo TK. et al Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital. J Virol Methods 2005; 128: 156-161
• 42 Wurtzer S, Marechal V, Mouchel JM. et al Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral genome quantification in Paris wastewaters. medRxiv. 2020 Posted May 06, 2020
• 43 Zheng S, Fan J, Yu F. et al Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020; 369: m1443